Global Automated and Rapid Microbiological Tests Bussiness Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Automated and Rapid Microbiological Tests Bussiness Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Automatic rapid microbial detection is a replacement of the age-old manual method for counting colonies and rooting out contamination. Rapid methods remove well-trained, highly paid microbiologists from tedious quality control processes, freeing up their labor for more innovative and impactful work. Given the right instruments, automation also enables higher throughputs and greater accuracy in results.
Automated and Rapid Microbiological Tests Bussiness report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Automated and Rapid Microbiological Tests Bussiness market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinical and Non-Clinical are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Automated and Rapid Microbiological Tests Bussiness industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Automated and Rapid Microbiological Tests Bussiness key companies include Abbott Laboratories, Roche, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories, Cellabs, Celsis International, Gen-Probe and Sekisui Diagnostics, etc. Abbott Laboratories, Roche, Becton Dickinson and Company are top 3 players and held % share in total in 2022.
Automated and Rapid Microbiological Tests Bussiness can be divided into Automated Identification & Susceptibility Systems, Automated Blood Culture Systems, Automated Tuberculosis Systems and Streptococcal Infection Rapid Tests, etc. Automated Identification & Susceptibility Systems is the mainstream product in the market, accounting for % share globally in 2022.
Automated and Rapid Microbiological Tests Bussiness is widely used in various fields, such as Clinical and Non-Clinical, etc. Clinical provides greatest supports to the Automated and Rapid Microbiological Tests Bussiness industry development. In 2022, global % share of Automated and Rapid Microbiological Tests Bussiness went into Clinical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Automated and Rapid Microbiological Tests Bussiness market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Abbott Laboratories
Roche
Becton Dickinson and Company
BioMerieux SA
Bio-Rad Laboratories
Cellabs
Celsis International
Gen-Probe
Sekisui Diagnostics
MedMira
Meridian Biosciences
Orasure Technologies
Orion Diagnostica Oy
Quidel Corporation
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Remel
Oxoid Limited
Segment by Type
Automated Identification & Susceptibility Systems
Automated Blood Culture Systems
Automated Tuberculosis Systems
Streptococcal Infection Rapid Tests
GC/Chlamydia Rapid Tests
Other
Clinical
Non-Clinical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Automated and Rapid Microbiological Tests Bussiness market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Automated and Rapid Microbiological Tests Bussiness introduction, etc. Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Automated and Rapid Microbiological Tests Bussiness market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Automated and Rapid Microbiological Tests Bussiness report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Automated and Rapid Microbiological Tests Bussiness market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinical and Non-Clinical are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Automated and Rapid Microbiological Tests Bussiness industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Automated and Rapid Microbiological Tests Bussiness key companies include Abbott Laboratories, Roche, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories, Cellabs, Celsis International, Gen-Probe and Sekisui Diagnostics, etc. Abbott Laboratories, Roche, Becton Dickinson and Company are top 3 players and held % share in total in 2022.
Automated and Rapid Microbiological Tests Bussiness can be divided into Automated Identification & Susceptibility Systems, Automated Blood Culture Systems, Automated Tuberculosis Systems and Streptococcal Infection Rapid Tests, etc. Automated Identification & Susceptibility Systems is the mainstream product in the market, accounting for % share globally in 2022.
Automated and Rapid Microbiological Tests Bussiness is widely used in various fields, such as Clinical and Non-Clinical, etc. Clinical provides greatest supports to the Automated and Rapid Microbiological Tests Bussiness industry development. In 2022, global % share of Automated and Rapid Microbiological Tests Bussiness went into Clinical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Automated and Rapid Microbiological Tests Bussiness market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Abbott Laboratories
Roche
Becton Dickinson and Company
BioMerieux SA
Bio-Rad Laboratories
Cellabs
Celsis International
Gen-Probe
Sekisui Diagnostics
MedMira
Meridian Biosciences
Orasure Technologies
Orion Diagnostica Oy
Quidel Corporation
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Remel
Oxoid Limited
Segment by Type
Automated Identification & Susceptibility Systems
Automated Blood Culture Systems
Automated Tuberculosis Systems
Streptococcal Infection Rapid Tests
GC/Chlamydia Rapid Tests
Other
Segment by Application
Clinical
Non-Clinical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Automated and Rapid Microbiological Tests Bussiness market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Automated and Rapid Microbiological Tests Bussiness introduction, etc. Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Automated and Rapid Microbiological Tests Bussiness market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices